Cargando…
A Coronary Artery Disease Monitoring Model Built from Clinical Data and Alpha-1-Antichymotrypsin
Coronary artery disease (CAD) is one of the most common subtypes of cardiovascular disease. The progression of CAD initiates from the plaque of atherosclerosis and coronary artery stenosis, and eventually turns into acute myocardial infarction (AMI) or stable CAD. Alpha-1-antichymotrypsin (AACT) has...
Autores principales: | Chang, Chen-Chi, Tsai, I-Jung, Shen, Wen-Chi, Chen, Hung-Yi, Hsu, Po-Wen, Lin, Ching-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222053/ https://www.ncbi.nlm.nih.gov/pubmed/35741224 http://dx.doi.org/10.3390/diagnostics12061415 |
Ejemplares similares
-
Expression of alpha-1-antichymotrypsin in prostate carcinoma.
por: Cho, N. H., et al.
Publicado: (1997) -
A clinical perspective on the utility of alpha 1 antichymotrypsin for the early diagnosis of calcific aortic stenosis
por: Martin-Rojas, Tatiana, et al.
Publicado: (2017) -
Alpha-1-antichymotrypsin as a novel biomarker for diagnosis, prognosis, and therapy prediction in human diseases
por: Jin, Yanxia, et al.
Publicado: (2022) -
Plasma levels of alpha-1-antichymotrypsin are elevated in patients with chronic heart failure, but are of limited prognostic value
por: Lok, S. I., et al.
Publicado: (2014) -
Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases
Publicado: (1988)